Signaling through the lymphotoxin-β receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-α

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 6016-6023

  Marshall, William L ^a   Brinkman, Brigitta M N ^a   Ambrose, Christine M ^b   Pesavento, Patricia A ^a   Uglialoro, Adele M ^a   Teng, Edna ^a   Finberg, Robert W ^a   Browning, Jeffrey L ^b   Goldfeld, Anne E ^a,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BIOGEN   (United States)

^c CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; COCULTURE; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS REPLICATION;

ANTIGENS, CD; CELL LINE; DRUG SYNERGISM; HIV-1; HUMANS; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; MEMBRANE PROTEINS; MONOCYTES; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0033562999     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Mellors, J., C. Rinaldo, P. Gupta, R. White, J. Todd, and L. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167.
2. Shearer, W., T. Quinn, P. LaRussa, J. Lew, and W. S. Group. 1997. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N. Engl. J. Med. 336:1337.
3. Cao, Y., P. Krogstad, B. Korber, R. Koup, M. Muldoon, C. Macken, J. Song, Z. Jin, J. Zhao, S. Clapp, et al. 1997. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat. Med. 3:549.
4. + cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. J. Pediatr. 130:890.
5. O'Shea, S., M. Newell, D. Dunn, M. Garcia-Rodriguez, I. Bates, J. Mullen, T. Rostron, K. Corbett, S. Aiyer, K. Butler, et al. 1998. Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J. Med. Virol. 54:113.
6. Pontesilli, O., M. Klein, S. Kerkhof-Garde, N. Pakker, F. de Wolf, H. Schuitemaker, and F. Miedema. 1997. Kinetics of immune functions and virus replication during HIV-1 infection. Immunol. Lett. 57:125.
7. Fauci, A. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529.
8. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Dun, J. H. Kehrl, and A. S. Fauci. 1989. Tumor necrosis factor a induces expression of human immunodeficiency virus in chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365.
9. Poli, G., A. Kinter, J. Justement, J. Kehrl, P. Bressler, S. Stanley, and A. Fauci. 1990. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87: 782.
10. Kriegler, M., C. Perez, K. DeFay, I. Albert, and S. Lu. 1988. A novel form of TNF/cachectin in a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45.
11. Bazzoni, F., and B. Beutler. 1995. How do tumor necrosis factor receptors work? J. Inflamm. 45:221.
12. Hsu, H., J. Xiong, and D. V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495.
13. Rothe, M., V. Sarma, V. M. Dixit, D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
14. Engelmann, H., H. Holtmann, C. Brakebush, Y. S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497.
15. Espevik, T., M. Brockhaus, H. Loetscher, U. Nonstad, and R. Shalaby. 1990. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171:415.
16. Grell, M., H. Douni, M. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, et al. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa TNF receptor. Cell 83:793.
17. Matsumoto, M. Y.-X. Fu, H. Molina, and D. Chaplin. 1997. Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137.
18. MacKay, F., G. Majeau, P. Lawton, P. Hochman, and J. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033.
19. Rennart, P., J. Browning, R. Mebius, F. Mackay, and P. Hochman. 1996. Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999.
20. Murphy, M., B. N. Walter, L. Pike-Noble, N. A. Fanger, P. Guyre, J. L. Browning, C. F. Ware, and L. B. Epstein. 1998. Expression of lymphotoxin-β receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ. 5:497.
21. Chaplin, D. D., and Y.-X. Fu. 1998. Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10:289.
22. MacKay, F., and J. L. Browning. 1998. Turning off follicular dendritic cells. Nature 395:26.
23. Mauri, D., R. Ebner, R. Montgomery, K. Kochel, T. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. Eisenberg, G. Cohen, et al. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin-α are ligands for herpesvirus entry mediator. Immunity 8:21.
24. Marino, M., A. Dunn, D. Grail, M. Ingleses, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093.
25. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-α deficient mice: a critical requirement for TNF in germinal center formation and in the maturation of the humoral immune response. Eur. Cytokine Netw. 7:227.
26. Cook, M. C., H. Korner, D. S. Riminton, F. A. Lemckert, J. Hasbold, M. Amesbury, P. D. Hodgkin, J. G. Cyster, J. D. Sedgwick, and A. Basten. 1998. Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J. Exp. Med. 188:1503.
27. Le Hir, M., H. Bluethmann, M. Kosco-Vilbois, M. Muller, F. di Padova, M. Moore, B. Ryffel, and H.-P. Eugster. 1996. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 183:2367.
28. Boussiotis, V. A., L. Nadler, J. L. Strominger, and A. E. Goldfeld. 1994. Tumor necrosis factor-α is an autocrine growth factor for activated B cells. Proc. Natl. Acad. Sci. USA 91:7007.
29. + cells in lymph node fine needle aspiration biopsies with HIV clinical status: a preliminary study. Acta Cytolog. 41:1762.
30. Haase, A., K. Henry, M. Zupanic, G. Sedgwick, R. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z.-Q. Zhang, et al. 1996. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274:985.
31. Embertson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
32. Balter, M. 1996. HIV's other immune system targets: macrophages. Science 274: 1464.
33. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature 339:70.
34. Folks, T., J. Justement, C. Dinarello, and A. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800.
35. Marshall, W., D. Diamond, M. Kowalski, and R. Finberg. 1992. High level of surface CD4 prevents stable HIV infection of T cell transfectants. J. Virol. 66: 5492.
36. Marshall, W. L., E.S. Mittler, P. Avery, J. A. Lawrence, and R. W. Finberg. 1994. Glycosylphosphatidylinositol-anchored CD4 supports HIV-1 replication, but not cytopathic effect, in T cell transfeclants. J. Virol. 68:4039.
37. Browning, J., I. Dougas, A. Ngam-ek, P. Bourdon, B. Ehrenfels, K. Miatowski, M. Zafari, A. Yampaglia, P. Lawton, W. Meier, et al. 1995. Characterization of surface lymphotoxin forms: use of specific antibodies and soluble receptors. J. Immunol. 154:33.
38. Browning, J., K. Miatkowski, D. Griffiths, P. Bourdon, C. Hession, C. Ambrose, and W. Meier. 1996. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins α and β. J. Biol. Chem. 271: 8618.
39. Browning, J., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. Benjamin, W. Meier, and F. MacKay. 1996. Signaling through the Lymphotoxin-β receptor induces the death of some adenocarcinoma tumor cell lines. J. Exp. Med. 183: 867.
40. Brockhaus, M., H. Schoenfeld, E. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87: 3127.
41. Bergelson, J., M. Shepley, B. Chan, M. Hemler, and R. Finberg. 1992. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718.
42. Tsitsikov, E., R. Fuleihan, K. McIntosh, P. Scholl, and R. Geha. 1995. Cross-linking of Fcγ receptors activates HIV-1 long terminal repeat-driven transcription in human monocytes. Int. Immunol. 7:1665.
43. Matsuyama, T., A. Yamada, J. Kay, K. Yamada, S. Akiyama, S. Schlossman, and C. Morimoto. 1989. Activation of CD4 cells by fibronectin and anti-CD3 antibody. J. Exp. Med. 170:1133.
44. Goldfeld, A. E., P. G. McCaffrey, J. L. Strominger, and A. Rao. 1993. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor a gene promoter. J. Exp. Med. 178:1365.
45. Chicheportiche, Y., P. Bourdon, H. Xu, Y. Hsu, H. Scott, C. Hession, I. Garcia, and J. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272:32401.
46. Crowe, P., T. VanArsdale, B. Walter, C. Ware, C. Hession, B. Ehrenfels, J. Browning, W. Din, R. Goodwin, and C. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707.
47. Nicoletti, I., G. Migliorati, M. C. Pagliacc, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
48. Mackay, F., G. Majeau, P. Hochman, and J. Browning. 1996. Lymphotoxin β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types. J. Biol. Chem. 271:24934.
49. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family value. Cell 80:529.
50. Nakano, H., H. Oshima, W. Chung, L. Williams-Abbott, C. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:14661.
51. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Marxio, S. Marmon, R. Sutton, C. Hill, et al. 1996. Identification of a major coreceptor for primary isolates of HIV-1. Nature 381:661.
52. Rucker, J., M. Samson, B. Doranz, F. Libert, J. Berson, Y. Yo., R. Smyth, R. Collman, C. Broder, G. Vassart, et al. 1996. Regions in B-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437.
53. Rottman, J., K. Ganley, K. Williams, L. Wu, C. Mackay, and D. Ringler. 1997. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151:1341.
54. Pinchuk, L., P. Polacino, M. Agy, S. Klaus, and E. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1:317.
55. Mackay, F., P. Bourdon, D. Griffiths, P. Lawton, M. Zafari, I. Sizing, K. Miatkowski, A. Ngam-ek, C. Benjamin, C. Hession, et al. 1997. Cytotoxic activities of recombinant soluble murine lymphotoxin-α and lymphotoxin-α/β complexes. J. Immunol. 159:3299.
56. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. Van Arsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389.
57. Liu, Z. G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor I effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565.
58. Declercq, W., G. Denecker, W. Fiers, and P. Vandenabeele. 1998. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J. Immunol. 161:390.
59. Lazdins, J., M. Grell, M. Walker, K. Woods-Cook, P. Scheurich, and K. Pfizenmaier. 1997. Membrane tumor necrosis factor (TNF) induced cooperalive signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells. J. Exp. Med. 185:81.
60. Said, J. 1997. Humman immunodeficiency virus-related lymphoid proliferations. Semin. Diag. Pathol. 14:48.
61. Amadori, A., and L. Chieco-Bianchi. 1990. B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol. Today 374.
62. Terpstra, F. G., B. J. Al, M. T. L. Roos, F. DeWolf, J. Goudsmit, P. T. A. Schellekens, and F. Miedema. 1989. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur. J. Immunol. 19:667.
63. Mizuma, H., S. Litwin, and S. Zolla-Pazner. 1988. B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters. Clin. Exp. Immunol. 71:410.
64. Finkel, T., G. Tudor-Williams, N. Banda, M. Cotton, T. Curiel, C. Monks, T. Baba, R. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nat. Med. 1:129.
65. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355.